Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18660160 | COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF | May 2024 | November 2025 | Allow | 18 | 2 | 1 | No | No |
| 18649759 | NICOTINE TABLET | April 2024 | June 2025 | Allow | 13 | 0 | 1 | No | No |
| 18596096 | COMPOSITIONS FOR CONTROLLING A PLANT DISEASE | March 2024 | October 2025 | Allow | 20 | 1 | 1 | No | No |
| 18526914 | NOVEL WOUND DRESSING BASED ON CELLULOSE ACETATE FILMS CONTAINING BINARY METAL OXIDE NANOHYBRIDS | December 2023 | May 2025 | Abandon | 17 | 3 | 0 | No | No |
| 18506928 | UV PROTECTANT FORMULATIONS | November 2023 | October 2025 | Abandon | 24 | 4 | 1 | Yes | No |
| 18221957 | NOVEL WOUND DRESSING BASED ON CELLULOSE ACETATE FILMS CONTAINING BINARY METAL OXIDE NANOHYBRIDS | July 2023 | February 2025 | Abandon | 19 | 3 | 1 | No | No |
| 18348891 | NICOTINE TABLET | July 2023 | February 2024 | Allow | 8 | 0 | 0 | Yes | No |
| 18199322 | COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF | May 2023 | October 2025 | Allow | 29 | 2 | 1 | Yes | No |
| 18032659 | COMPOSITIONS FOR TREATING INFLAMMATIONS, WOUNDS AND SCARRING | April 2023 | January 2026 | Abandon | 33 | 0 | 1 | No | No |
| 18030149 | THREE-DIMENSIONAL IMPLANTABLE MATRIX WITH REDUCED FOREIGN BODY RESPONSE | April 2023 | September 2024 | Allow | 17 | 2 | 1 | No | No |
| 18167574 | METHOD OF PREPARING A DEGRADABLE PRODUCT | February 2023 | January 2026 | Abandon | 35 | 5 | 0 | No | No |
| 18161230 | IONIZING IRRADIATION STERILIZATION OF BACTERIAL MINICELL-BASED BIOPHARMACEUTICALS AND METHODS OF USE | January 2023 | June 2025 | Allow | 28 | 0 | 0 | No | No |
| 18102666 | Hemp Essential Oil | January 2023 | November 2025 | Abandon | 34 | 0 | 1 | No | No |
| 18146189 | ANTIBACTERIAL MAGNESIUM HYDROXIDE COMPOSITION | December 2022 | April 2024 | Allow | 15 | 1 | 0 | No | No |
| 17922674 | ANTIBIOTIC AND ANTI-INFLAMMATORY COMPOSITIONS AND METHODS OF USE | November 2022 | August 2025 | Abandon | 34 | 0 | 1 | No | No |
| 17995226 | OXIDATIVE STRESS INHIBITOR AND ANTIOXIDANT AGENT | September 2022 | June 2025 | Abandon | 33 | 1 | 0 | No | No |
| 17905098 | ANTIMICROBIAL MATERIAL | August 2022 | July 2025 | Abandon | 34 | 0 | 1 | No | No |
| 17801900 | SWELLABLE ANTIMICROBIAL FIBRE | August 2022 | August 2025 | Abandon | 36 | 0 | 1 | No | No |
| 17787128 | CATHETER DEVICE FOR RELEASING PHARMACEUTICALLY ACTIVE COMPOUNDS OVER AN EXTENDED PERIOD | June 2022 | October 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17744811 | Antibacterial Glucose-based Composite Nanoparticle and Processing Method and Use thereof | May 2022 | May 2025 | Allow | 36 | 1 | 1 | No | No |
| 17741853 | EMOLLIENT EMULSION | May 2022 | November 2023 | Abandon | 19 | 1 | 0 | Yes | No |
| 17772232 | METHOD OF ADMINISTERING SEABERRRY AND SAW PALMETTO EXTRACTS TO INHIBIT 5a-REDUCTASE ACTIVITY | April 2022 | May 2025 | Allow | 37 | 1 | 1 | No | No |
| 17694557 | PERSONAL CARE AEROSOL COMPOSITIONS, METHODS AND DEVICES | March 2022 | April 2025 | Abandon | 37 | 3 | 0 | No | No |
| 17648302 | Modified Nano-Silica Gel for Improving Symptoms Caused by Bacteria and Viruses and Preparation Method and Application Thereof | January 2022 | April 2024 | Allow | 27 | 1 | 1 | No | No |
| 17577935 | CACTI AND CACTI PARTS FOR COSMETIC TREATMENT OF SKIN AND BALDNESS AND HAIR REGENERATION AND REGROWTH | January 2022 | December 2023 | Abandon | 23 | 1 | 0 | No | No |
| 17573824 | COMPOSITIONS FOR BEAUTY PRODUCTS AND METHODS OF MAKING SAME | January 2022 | January 2024 | Abandon | 24 | 0 | 1 | No | No |
| 17619488 | EXTERNAL COMPOSITION FOR SKIN HAVING ITCHING RELIEVING EFFECT | December 2021 | October 2025 | Abandon | 47 | 2 | 1 | No | No |
| 17544672 | CLEANSER | December 2021 | May 2024 | Abandon | 29 | 1 | 1 | No | No |
| 17596067 | DEAD SEA MINERAL BASED IMPLEMENTATION IN HIGH PERFORMANCE NONWOVEN FABRICS | December 2021 | February 2024 | Abandon | 27 | 1 | 1 | No | No |
| 17455359 | DEVICES AND METHODS FOR REDUCING CYSTINE CRYSTALS IN VIVO | November 2021 | September 2024 | Allow | 34 | 3 | 1 | No | No |
| 17454673 | NASAL SEPTUM CARTILAGE COMPOSITIONS AND METHODS | November 2021 | September 2025 | Abandon | 46 | 1 | 1 | No | No |
| 17609699 | EXTRACTION OF CANNABINOIDS FROM BIOMASS | November 2021 | July 2025 | Abandon | 44 | 1 | 1 | No | No |
| 17608682 | AGENT FOR REDUCING MALODOR OF FLATULENCE AND/OR STOOL | November 2021 | June 2024 | Abandon | 31 | 2 | 0 | No | No |
| 17453239 | TOPICAL COMPOSITION FOR CONTROL OF DEMODEX | November 2021 | June 2025 | Abandon | 44 | 4 | 1 | No | No |
| 17513800 | Microstructured Textile with Microencapsulated Compounds | October 2021 | October 2024 | Abandon | 36 | 3 | 1 | Yes | No |
| 17606925 | Pharmaceutical Composition Comprising Venetoclax | October 2021 | March 2025 | Abandon | 40 | 0 | 1 | No | No |
| 17504338 | CLAY MINERAL-BASED TREATMENTS IN PSEUDOMONAS AERUGINOSA INFECTION CONTROL | October 2021 | September 2024 | Abandon | 35 | 2 | 1 | No | No |
| 17491005 | METHODS, COMPOSITIONS AND ARTICLES FOR OLFACTORY-ACTIVE SUBSTANCES | September 2021 | June 2025 | Abandon | 45 | 3 | 0 | No | No |
| 17466455 | Method of Using Cannabinoids Encapsulated in Phospholipid Carriers for Transmucosal and Transdermal Administration | September 2021 | November 2023 | Abandon | 26 | 1 | 0 | No | No |
| 17479122 | BIOBASED, BIODEGRADABLE COMPOSITE POWDER FOR USE IN COSMETICS | September 2021 | April 2025 | Allow | 43 | 4 | 1 | No | No |
| 17281742 | ORAL COMPOSITION COMPRISING B-ESCIN AND THE USE THEREOF | August 2021 | November 2025 | Abandon | 55 | 1 | 0 | No | No |
| 17429543 | COMPOSITION FOR PREVENTING OR TREATING TINNITUS COMPRISING VITIS VINIFERA LEAF EXTRACT AS ACTIVE INGREDIENT | August 2021 | January 2026 | Allow | 53 | 3 | 0 | No | No |
| 17427868 | METHOD FOR PRODUCING GELATINOUS COMPOSITION | August 2021 | June 2025 | Abandon | 47 | 2 | 1 | Yes | No |
| 17423627 | TITANIUM PHOSPHATE POWDER AND WHITE PIGMENT FOR COSMETIC PREPARATIONS | July 2021 | January 2025 | Abandon | 42 | 2 | 0 | No | No |
| 17423705 | SOLID MICRONIZED MELATONIN COMPOSITION | July 2021 | May 2025 | Abandon | 46 | 2 | 1 | No | No |
| 17423706 | COMPOSITION FOR PREVENTING OR TREATING PROSTATIC HYPERPLASIA COMPRISING MIXED EXTRACTS OF CURCUMAE RADIX AND SYZYGII FLOS | July 2021 | July 2025 | Allow | 48 | 2 | 0 | Yes | No |
| 17418990 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MALE SEXUAL DYSFUNCTION | June 2021 | August 2024 | Abandon | 38 | 1 | 0 | No | No |
| 17353906 | GAS MIXTURES CONTAINING LOW CONCENTRATIONS OF XENON AND ARGON PROVIDE NEUROPROTECTION WITHOUT INHIBITING THE CATALYTIC ACTIVITY OF THROMBOLYTIC AGENTS | June 2021 | August 2023 | Abandon | 26 | 1 | 0 | No | No |
| 17415258 | CANNABIS COMPOSITIONS AND METHODS | June 2021 | March 2025 | Abandon | 45 | 1 | 1 | No | No |
| 17348219 | PHARMACEUTICAL USE | June 2021 | December 2025 | Allow | 54 | 4 | 0 | Yes | No |
| 17295535 | SINGLE-DOSE USE OF A COMPOSITION COMPRISING A PARTICULAR MIXTURE OF GRAPE EXTRACT AND BLUEBERRY EXTRACT | May 2021 | November 2024 | Abandon | 42 | 1 | 1 | No | No |
| 17321697 | Moisturizer Sheets | May 2021 | July 2023 | Abandon | 26 | 1 | 1 | No | No |
| 17293582 | AGENT FOR PREVENTING AND/OR TREATING NEURODEGENERATIVE DISEASES | May 2021 | July 2024 | Abandon | 38 | 0 | 1 | No | No |
| 17319076 | NOVEL ENCAPSULATED COSMETIC COMPOSITIONS AND USES THEREOF | May 2021 | February 2025 | Abandon | 45 | 3 | 1 | No | No |
| 17318346 | UV Protectant Formulations | May 2021 | January 2025 | Abandon | 44 | 4 | 1 | No | No |
| 17306293 | HAND CLEANING COMPOSITION WITH TIMED USE DURATION | May 2021 | February 2024 | Abandon | 34 | 2 | 0 | No | No |
| 17289575 | COMPOSITION OF ACTIVE INGREDIENTS, FOR CARE AND SURFACE MODIFICATION OF HUMAN HAIR | April 2021 | August 2024 | Abandon | 39 | 1 | 1 | No | No |
| 17286253 | Composition for Neuroprotection, Containing Plant Extract or Fraction as Active Ingredient | April 2021 | March 2025 | Abandon | 47 | 2 | 0 | No | No |
| 17230979 | PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | April 2021 | April 2023 | Allow | 24 | 1 | 0 | No | No |
| 17280101 | COMBINATION OF BACTERIAL BIOLOGICAL CONTROL AGENT AND FATTY ACIDS | March 2021 | September 2025 | Allow | 54 | 3 | 1 | No | No |
| 17277341 | SELF-ASSEMBLING GRAPHENE OXIDE-PROTEIN MATRIX | March 2021 | November 2025 | Allow | 56 | 2 | 1 | Yes | No |
| 17277093 | COMPOSITIONS AND METHODS FOR TREATING BONE INJURY | March 2021 | September 2025 | Allow | 54 | 2 | 1 | No | No |
| 17198783 | COSMETIC COMPOSITION COMPRISING AMIDE-BASED COMPOUND | March 2021 | July 2023 | Allow | 28 | 1 | 1 | No | No |
| 17269940 | Cannabis-Infused Product with Extended Cannabinoid Profile User Experience | February 2021 | August 2024 | Abandon | 41 | 1 | 1 | No | No |
| 17269921 | Cannabis-Infused Product with Controlled Cannabinoid Profile User Experience | February 2021 | August 2024 | Abandon | 42 | 1 | 1 | No | No |
| 17254347 | LACTOBACILLUS PLANTARUM FOR SKIN CARE | December 2020 | June 2024 | Allow | 42 | 2 | 1 | No | No |
| 17127171 | BIODEGRADABLE IRON-BASED ALLOY COMPOSITION, MEDICAL IMPLANT APPLYING THE SAME, AND MANUFACTURING METHOD THEREOF | December 2020 | April 2025 | Abandon | 52 | 4 | 1 | No | No |
| 17253312 | COSMETIC COMPOSITION BASED ON JANUS PARTICLES | December 2020 | March 2025 | Allow | 51 | 4 | 1 | Yes | No |
| 17054310 | BLOCK COPOLYMER-CONTAINING INORGANIC PARTICLE DISPERSION FOR COSMETICS | November 2020 | January 2026 | Abandon | 60 | 6 | 0 | Yes | No |
| 17090954 | ANTIMICROBIAL FIBER COMPRISING SILVER, FABRIC AND WOUND DRESSING COMPRISING THE ANTIMICROBIAL FIBER, AND METHODS FOR MANUFACTURING THE FIBER, THE FABRIC, AND THE WOUND DRESSING | November 2020 | June 2024 | Abandon | 43 | 2 | 1 | No | No |
| 17049794 | METHOD FOR MANUFACTURING POROUS INORGANIC PARTICLE AND LIGHT-REFLECTING COMPOSITION COMPRISING POROUS INORGANIC PARTICLE | October 2020 | July 2024 | Allow | 45 | 3 | 1 | No | No |
| 17047473 | COMPOSITIONS INFUSED WITH NICOTINE COMPOUNDS AND METHODS OF USE THEREOF | October 2020 | February 2024 | Abandon | 40 | 0 | 1 | No | No |
| 17046976 | SURFACE, AIR, TEXTILE, PAINT, PLASTIC, SILICONE AND WOOD, POLYETHYLENE; METAL AND DERIVATIVES ANTIMICROBIAL PROPERTIES | October 2020 | July 2023 | Abandon | 33 | 0 | 1 | No | No |
| 17043652 | COSMETIC | September 2020 | June 2023 | Allow | 32 | 2 | 0 | No | No |
| 17041699 | OIL AGENT-CONTAINING SILICONE ELASTOMER PARTICLE AND USE THEREOF IN COSMETIC COMPOSITION, ETC. | September 2020 | July 2024 | Allow | 46 | 3 | 1 | Yes | No |
| 16975252 | PACKAGE AND METHOD FOR PRODUCING THE SAME | August 2020 | May 2024 | Allow | 44 | 1 | 1 | Yes | No |
| 16998655 | INCENSE MATERIAL AND METHOD OF MANUFACTURE THEREOF | August 2020 | July 2023 | Abandon | 35 | 1 | 1 | No | No |
| 16985891 | LONG-TERM RE-ABSORBABLE SUBCUTANEOUS IMPLANT WITH CONTROLED PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE POLYMER SUBSTANCE RELEASE FOR TREATING ENDOMETRIOSIS | August 2020 | August 2023 | Abandon | 36 | 5 | 0 | No | Yes |
| 16965214 | COMPOSITION FOR PREVENTING HAIR LOSS AND PROMOTING HAIR GROWTH AND METHOD FOR PREPARING THE SAME | July 2020 | May 2024 | Abandon | 46 | 3 | 1 | No | No |
| 16962791 | ANTIMICROBIAL PRESERVATIVE COMPOSITIONS | July 2020 | July 2025 | Allow | 60 | 5 | 1 | Yes | No |
| 16908661 | COMPOSITION FOR BONE DEFECT AND PREPARATION METHOD OF THE SAME AND KIT FOR THE SAME | June 2020 | October 2023 | Allow | 40 | 3 | 0 | No | No |
| 16896011 | LYCOPENE MICRO-CAPSULE POWDER AND PREPARATION METHOD THEREOF | June 2020 | May 2023 | Allow | 35 | 2 | 1 | No | No |
| 16894851 | EMOLLIENT EMULSION | June 2020 | August 2022 | Abandon | 27 | 2 | 1 | Yes | No |
| 16894171 | INJECTABLE MESH | June 2020 | May 2025 | Abandon | 59 | 6 | 1 | Yes | No |
| 16766814 | COMPOSITION FOR TOPICAL SKIN CARE | May 2020 | July 2023 | Abandon | 37 | 3 | 1 | No | No |
| 16766514 | ANTI-INFLAMMATORY COMPOSITION COMPRISING GRAPHENE NANO-STRUCTURE | May 2020 | June 2023 | Allow | 37 | 4 | 1 | No | No |
| 16761270 | SYNERGISTIC COMPOSITION FOR UNIVERSAL INCREASE OF AGRICULTURAL PRODUCTION | May 2020 | March 2023 | Abandon | 34 | 1 | 1 | No | No |
| 16863408 | System and Method for Disinfecting an Occupied Environment Using Direction Controlled Germicidal Radiation | April 2020 | March 2023 | Abandon | 35 | 1 | 1 | No | No |
| 16758641 | PREVENTIVE AND/OR THERAPEUTIC AGENT FOR DEMENTIA | April 2020 | November 2022 | Abandon | 30 | 2 | 1 | No | No |
| 16835514 | COMPOUND, COMPOSITION AND METHOD FOR PROTECTING SKIN FROM TEMPERATURE EXTREMES | March 2020 | July 2021 | Abandon | 15 | 0 | 1 | No | No |
| 16835351 | DEODORANT COMPOSITIONS | March 2020 | June 2024 | Allow | 50 | 6 | 0 | Yes | No |
| 16832461 | RAPID SET GEL CONCENTRATE FOR MEDICAL PRODUCTS | March 2020 | November 2022 | Abandon | 31 | 2 | 1 | No | No |
| 16829214 | LEAVE-ON LIGHT OIL HAIR COMPOSITION | March 2020 | November 2024 | Allow | 56 | 7 | 1 | Yes | No |
| 16829157 | Pest-Repellent Compositions | March 2020 | November 2023 | Abandon | 44 | 3 | 1 | No | No |
| 16825301 | PERSONAL CARE AEROSOL COMPOSITIONS, METHODS AND DEVICES | March 2020 | May 2022 | Abandon | 26 | 2 | 0 | No | No |
| 16649541 | DEVICES AND METHODS FOR REDUCING CYSTINE CRYSTALS IN VIVO | March 2020 | March 2022 | Abandon | 24 | 1 | 1 | No | No |
| 16811971 | Disinfectant Composition Against the Novel Wuhan Corona Virus COVID-19 | March 2020 | December 2021 | Abandon | 22 | 2 | 0 | No | No |
| 16810710 | DIHYDROMYRICETIN NANOPARTICLE FORMULATIONS | March 2020 | December 2022 | Abandon | 33 | 2 | 1 | No | No |
| 16806671 | METHOD OF USING MACROCYCLIC ACTIVATED PEROXIDES FOR MICROBE REDUCTION | March 2020 | January 2022 | Abandon | 22 | 2 | 0 | No | No |
| 16801081 | SKIN TREATMENT | February 2020 | April 2022 | Abandon | 26 | 2 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ALAM, AYAAN A.
With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 42.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner ALAM, AYAAN A works in Art Unit 1611 and has examined 120 patent applications in our dataset. With an allowance rate of 32.5%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 38 months.
Examiner ALAM, AYAAN A's allowance rate of 32.5% places them in the 5% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by ALAM, AYAAN A receive 2.57 office actions before reaching final disposition. This places the examiner in the 75% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by ALAM, AYAAN A is 38 months. This places the examiner in the 28% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +43.2% benefit to allowance rate for applications examined by ALAM, AYAAN A. This interview benefit is in the 89% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 16.2% of applications are subsequently allowed. This success rate is in the 13% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 17.4% of cases where such amendments are filed. This entry rate is in the 20% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 0% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 80.0% of appeals filed. This is in the 71% percentile among all examiners. Of these withdrawals, 25.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 106.7% are granted (fully or in part). This grant rate is in the 94% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 0% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.